Clinical Trial Update: Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous ferric carboxymaltose (Ferinject) in patients undergoing orthopedic surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: University Hospital Muenster | Conditions: Anemia, Orthopedic Surgery | Phase 4 | Status: TERMINATED